Clin Gastroenterol Hepatol. 2021 Jun 16;S1542-3565(21)00644-3.doi: 10.1016/j.cgh.2021.06.016. Online ahead of print.

Eugenia Uche-Anya ¹, Steffen Husby ², Gilaad G Kaplan ³, Fox E Underwood ³, Peter Hr Green ⁴, Benjamin Lebwohl ⁵

Author information

• ¹Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States.
• ²Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
• ³Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
• ⁴Celiac Disease Center, Columbia University Irving Medical Center, New York, New York, United States.
• ⁵Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States; Celiac Disease Center, Columbia University Irving Medical Center, New York, New York, United States; Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York, United States. Electronic address: BL114@cumc.columbia.edu.

Abstract

Surveillance Epidemiology Under Research Exclusion for Celiac Disease (SECURE-CELIAC) is an international, de-identified adult and pediatric database created to monitor and report on the severity of coronavirus disease 2019 (COVID-19) outcomes in patients with celiac disease (CD).